Skip to content

Eloxx Pharmaceuticals, Inc.

ELOX· NasdaqCore metricsCIK 1035354

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -3.45%
Market cap
$51.42M
4.04M shares
Filings
1,021
$0.00
FY 2025−100.0% FY25 yoy
-$4.50M
Q2 2026N/M FY25 yoy
-$4.45M
Q2 2026N/M FY25 yoy
-$12.33M
Q3 2023derivedN/M FY22 yoy
-$0.66
Q2 2026N/M FY25 yoy
$61.96M
Q2 2026+4,210.8% FY25 yoy
$51.42M
—
—
1.3×
—
—

FY2025 figures · derived

Price

$12.74+213.02%+$8.67since May 29, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$6.36M0FY 2010FY 2012FY 2013FY 2014FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$6,359,000reported
FY 20232023-12-31$0reported
FY 20142014-06-30$182,229reported
FY 20132013-06-30$7,819reported
FY 20122012-06-30$200,000reported
FY 20102010-06-30$140,000reported

Capital returns

Dividends and buybacks · FY2017 to FY2019
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2019$0.00—$0.00—40.12M sh+11.9%—
FY2018$0.00—$0.00—35.86M sh+30.3%—
FY2017$0.00—$0.00—27.53M sh+554.6%—
FY2010—$1.05M$1.05M————

Biological products, except diagnostic substances

Eloxx Pharmaceuticals, Inc. is the 123rd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Eloxx Pharmaceuticals, Inc. · CIK 1035354 · Engraved from SEC EDGAR